Author

Vadim Le Joncour

Primary ORCID profile (0000-0001-8153-8563 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Vadim Le JoncouriD1 paper · University of Helsinki

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Harri Sihto· 1 shared Heikki Joensuu· 1 shared Isabel Burghardt· 1 shared Juha Jääskeläinen· 1 shared Kaisa Lehti· 1 shared Maija Hyvönen· 1 shared Michael Weller· 1 shared Olli Tynninen· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Harri Sihto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 5, 2018

Vulnerability of invasive glioma cells to lysosomal membrane instabilization

Vadim Le Joncour, Maija Hyvönen, Pauliina Filppu…·Pirjo Laakkonen

This paper identifies MDGI as a biomarker for invasive glioma and shows that targeting lysosomal membrane permeabilization with clemastine reduces tumor viability and prolongs survival in preclinical models.

DOI 10.1101/276402

humanbulk RNA-seq

𝕏 PostBluesky